Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $10 Million Private Placement of SciSparc Ltd.
Press Release – New York, NY – June 1, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as exclusive placement agent in a $10,000,000 private placement offering of SciSparc Ltd. (NASDAQ: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system. The offering consisted of 3,546,100 units at a purchase price of $2.82 per unit, priced at-the-market under Nasdaq rules. Each unit consisted of 1 share of common stock and 2 non-tradable warrants at an exercise price of $2.57. The gross proceeds from the private placement offering were approximately $10 million.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, Barrett S. DiPaolo, and Jeffrey Cahlon.
- Sichenzia Ross Ference LLP Represents ThinkEquity LLC in $6.87 Million Public Offering of Common Stock of Twin Vee PowerCats Co. - October 4, 2022
- Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $5.75 Million Public Offering and Nasdaq Uplisting of Silo Pharma, Inc. - October 1, 2022
- Mid-Level Corporate Associate - September 29, 2022